25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

China Shineway Pharmaceutical Group Ltd ADR
Buy, Hold or Sell?

Let's analyze Shineway together

I guess you are interested in China Shineway Pharmaceutical Group Ltd ADR. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of China Shineway Pharmaceutical Group Ltd ADR. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about China Shineway Pharmaceutical Group Ltd ADR

I send you an email if I find something interesting about China Shineway Pharmaceutical Group Ltd ADR.

1. Quick Overview

1.1. Quick analysis of Shineway (30 sec.)










1.2. What can you expect buying and holding a share of Shineway? (30 sec.)

How much money do you get?

How much money do you get?
$4.74
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
$3.70
Expected worth in 1 year
$4.80
How sure are you?
88.9%

+ What do you gain per year?

Total Gains per Share
$5.84
Return On Investment
31.5%

For what price can you sell your share?

Current Price per Share
$18.53
Expected price per share
$18.53 - $22.08
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Shineway (5 min.)




Live pricePrice per Share (EOD)
$18.53
Intrinsic Value Per Share
$4.16 - $7.50
Total Value Per Share
$7.86 - $11.20

2.2. Growth of Shineway (5 min.)




Is Shineway growing?

Current yearPrevious yearGrowGrow %
How rich?$139.8m$129.4m$10.4m7.4%

How much money is Shineway making?

Current yearPrevious yearGrowGrow %
Making money$19.2m$15.1m$4.1m21.6%
Net Profit Margin21.5%18.3%--

How much money comes from the company's main activities?

2.3. Financial Health of Shineway (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Shineway?

Welcome investor! Shineway's management wants to use your money to grow the business. In return you get a share of Shineway.

First you should know what it really means to hold a share of Shineway. And how you can make/lose money.

Speculation

The Price per Share of Shineway is $18.53. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Shineway.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Shineway, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $3.70. Based on the TTM, the Book Value Change Per Share is $0.28 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.13 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $1.18 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Shineway.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.512.8%0.512.8%2.7014.6%1.648.9%1.739.3%
Usd Book Value Change Per Share0.281.5%0.281.5%-0.13-0.7%0.542.9%-1.43-7.7%
Usd Dividend Per Share1.186.4%1.186.4%0.904.9%1.126.0%0.864.6%
Usd Total Gains Per Share1.467.9%1.467.9%0.774.2%1.669.0%-0.57-3.1%
Usd Price Per Share18.80-18.80-12.12-19.46-22.05-
Price to Earnings Ratio36.80-36.80-4.49-16.85-41.47-
Price-to-Total Gains Ratio12.88-12.88-15.69-13.05-11.10-
Price to Book Ratio5.08-5.08-3.54-5.73-6.13-
Price-to-Total Gains Ratio12.88-12.88-15.69-13.05-11.10-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share18.53
Number of shares53
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share1.181.12
Usd Book Value Change Per Share0.280.54
Usd Total Gains Per Share1.461.66
Gains per Quarter (53 shares)77.3787.95
Gains per Year (53 shares)309.48351.80
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
125158299236115342
2502117608473231694
37531759177093461046
4100423412269464611398
51255292153511825771750
61507350184414196922102
71758409215316558072454
82009467246218929232806
922605262771212810383158
1025115843080236511533510

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%9.00.00.0100.0%10.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%2.01.00.066.7%4.01.00.080.0%7.02.00.077.8%8.02.00.080.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%9.00.00.0100.0%10.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%8.01.00.088.9%9.01.00.090.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of China Shineway Pharmaceutical Group Ltd ADR compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.2750.2750%-0.130+147%0.544-49%-1.426+618%
Book Value Per Share--3.7033.7030%3.427+8%3.426+8%8.573-57%
Current Ratio--3.3513.3510%4.072-18%4.330-23%4.873-31%
Debt To Asset Ratio--0.2650.2650%0.225+18%0.200+33%0.176+51%
Debt To Equity Ratio--0.3610.3610%0.290+25%0.255+41%0.218+65%
Dividend Per Share--1.1841.1840%0.902+31%1.115+6%0.860+38%
Eps--0.5110.5110%2.698-81%1.641-69%1.731-70%
Free Cash Flow Per Share--0.4480.4480%0.593-25%0.394+14%0.339+32%
Free Cash Flow To Equity Per Share--0.4350.4350%0.455-4%0.223+95%0.181+140%
Gross Profit Margin---13.481-13.4810%-15.943+18%-17.401+29%-9.223-32%
Intrinsic Value_10Y_max--7.499--------
Intrinsic Value_10Y_min--4.158--------
Intrinsic Value_1Y_max--0.539--------
Intrinsic Value_1Y_min--0.403--------
Intrinsic Value_3Y_max--1.781--------
Intrinsic Value_3Y_min--1.231--------
Intrinsic Value_5Y_max--3.219--------
Intrinsic Value_5Y_min--2.072--------
Market Cap699878100.000-1%710076000.000710076000.0000%457772400.000+55%741031426.460-4%2776637970.256-74%
Net Profit Margin--0.2150.2150%0.183+17%0.173+24%0.222-3%
Operating Margin--0.2150.2150%0.181+19%0.179+20%0.220-3%
Operating Ratio--0.7850.7850%0.819-4%0.821-4%0.924-15%
Pb Ratio5.004-1%5.0775.0770%3.536+44%5.726-11%6.133-17%
Pe Ratio36.274-1%36.80236.8020%4.492+719%16.850+118%41.467-11%
Price Per Share18.530-1%18.80018.8000%12.120+55%19.462-3%22.047-15%
Price To Free Cash Flow Ratio41.391-1%41.99541.9950%20.431+106%60.315-30%70.225-40%
Price To Total Gains Ratio12.693-1%12.87812.8780%15.687-18%13.054-1%11.102+16%
Quick Ratio--2.9802.9800%3.740-20%3.897-24%2.491+20%
Return On Assets--0.1010.1010%0.091+12%0.076+34%0.086+18%
Return On Equity--0.1380.1380%0.117+18%0.097+42%0.105+31%
Total Gains Per Share--1.4601.4600%0.773+89%1.659-12%-0.566+139%
Usd Book Value--139858194.690139858194.6900%129455552.808+8%130205358.406+7%410443860.559-66%
Usd Book Value Change Per Share--0.2750.2750%-0.130+147%0.544-49%-1.426+618%
Usd Book Value Per Share--3.7033.7030%3.427+8%3.426+8%8.573-57%
Usd Dividend Per Share--1.1841.1840%0.902+31%1.115+6%0.860+38%
Usd Eps--0.5110.5110%2.698-81%1.641-69%1.731-70%
Usd Free Cash Flow--16908767.23516908767.2350%22405629.816-25%14916144.068+13%14440441.038+17%
Usd Free Cash Flow Per Share--0.4480.4480%0.593-25%0.394+14%0.339+32%
Usd Free Cash Flow To Equity Per Share--0.4350.4350%0.455-4%0.223+95%0.181+140%
Usd Market Cap699878100.000-1%710076000.000710076000.0000%457772400.000+55%741031426.460-4%2776637970.256-74%
Usd Price Per Share18.530-1%18.80018.8000%12.120+55%19.462-3%22.047-15%
Usd Profit--19294334.25019294334.2500%15134440.437+27%12578643.727+53%45492932.404-58%
Usd Revenue--89884161.82589884161.8250%82723988.514+9%70510429.319+27%177784625.733-49%
Usd Total Gains Per Share--1.4601.4600%0.773+89%1.659-12%-0.566+139%
 EOD+4 -4MRQTTM+0 -0YOY+20 -165Y+21 -1510Y+20 -16

3.3 Fundamental Score

Let's check the fundamental score of China Shineway Pharmaceutical Group Ltd ADR based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1536.274
Price to Book Ratio (EOD)Between0-15.004
Net Profit Margin (MRQ)Greater than00.215
Operating Margin (MRQ)Greater than00.215
Quick Ratio (MRQ)Greater than12.980
Current Ratio (MRQ)Greater than13.351
Debt to Asset Ratio (MRQ)Less than10.265
Debt to Equity Ratio (MRQ)Less than10.361
Return on Equity (MRQ)Greater than0.150.138
Return on Assets (MRQ)Greater than0.050.101
Total7/10 (70.0%)

3.4 Technical Score

Let's check the technical score of China Shineway Pharmaceutical Group Ltd ADR based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than500.050
Ma 20Greater thanMa 5020.128
Ma 50Greater thanMa 10021.299
Ma 100Greater thanMa 20021.975
OpenGreater thanClose18.530
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About China Shineway Pharmaceutical Group Ltd ADR

China Shineway Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and trade of Chinese medicines in the People's Republic of China and Hong Kong. The company offers Chinese medicines in the form of injection, soft capsules, and granules; tablets, pills, oral liquid, and powder; and traditional Chinese medicine granules in various therapeutic areas, including respiratory system disease, nervous system, digestive system disease, cardiovascular and cerebrovascular, orthopedics, pediatrics, and other areas, as well as medication for strengthening the body. It is also involved in the trading of agricultural products; and research and development of Chinese pharmaceutical products. The company was incorporated in 2002 and is headquartered in Shijiazhuang, the People's Republic of China. China Shineway Pharmaceutical Group Limited operates as a subsidiary of BH Corporate Services Ltd.

Fundamental data was last updated by Penke on 2024-08-31 02:13:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating efficient.
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is fair priced.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Shineway earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Shineway to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 21.5% means that $0.21 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of China Shineway Pharmaceutical Group Ltd ADR:

  • The MRQ is 21.5%. The company is making a huge profit. +2
  • The TTM is 21.5%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ21.5%TTM21.5%0.0%
TTM21.5%YOY18.3%+3.2%
TTM21.5%5Y17.3%+4.1%
5Y17.3%10Y22.2%-4.8%
4.3.1.2. Return on Assets

Shows how efficient Shineway is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Shineway to the Drug Manufacturers - Specialty & Generic industry mean.
  • 10.1% Return on Assets means that Shineway generated $0.10 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of China Shineway Pharmaceutical Group Ltd ADR:

  • The MRQ is 10.1%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 10.1%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ10.1%TTM10.1%0.0%
TTM10.1%YOY9.1%+1.1%
TTM10.1%5Y7.6%+2.6%
5Y7.6%10Y8.6%-1.0%
4.3.1.3. Return on Equity

Shows how efficient Shineway is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Shineway to the Drug Manufacturers - Specialty & Generic industry mean.
  • 13.8% Return on Equity means Shineway generated $0.14 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of China Shineway Pharmaceutical Group Ltd ADR:

  • The MRQ is 13.8%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 13.8%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ13.8%TTM13.8%0.0%
TTM13.8%YOY11.7%+2.1%
TTM13.8%5Y9.7%+4.1%
5Y9.7%10Y10.5%-0.8%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of China Shineway Pharmaceutical Group Ltd ADR.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Shineway is operating .

  • Measures how much profit Shineway makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Shineway to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 21.5% means the company generated $0.21  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of China Shineway Pharmaceutical Group Ltd ADR:

  • The MRQ is 21.5%. The company is operating efficient. +1
  • The TTM is 21.5%. The company is operating efficient. +1
Trends
Current periodCompared to+/- 
MRQ21.5%TTM21.5%0.0%
TTM21.5%YOY18.1%+3.4%
TTM21.5%5Y17.9%+3.6%
5Y17.9%10Y22.0%-4.1%
4.3.2.2. Operating Ratio

Measures how efficient Shineway is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 0.79 means that the operating costs are $0.79 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of China Shineway Pharmaceutical Group Ltd ADR:

  • The MRQ is 0.785. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.785. The company is efficient in keeping operating costs low. +1
Trends
Current periodCompared to+/- 
MRQ0.785TTM0.7850.000
TTM0.785YOY0.819-0.034
TTM0.7855Y0.821-0.036
5Y0.82110Y0.924-0.103
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of China Shineway Pharmaceutical Group Ltd ADR.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Shineway is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 3.35 means the company has $3.35 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of China Shineway Pharmaceutical Group Ltd ADR:

  • The MRQ is 3.351. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.351. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.351TTM3.3510.000
TTM3.351YOY4.072-0.721
TTM3.3515Y4.330-0.979
5Y4.33010Y4.873-0.544
4.4.3.2. Quick Ratio

Measures if Shineway is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Shineway to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 2.98 means the company can pay off $2.98 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of China Shineway Pharmaceutical Group Ltd ADR:

  • The MRQ is 2.980. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.980. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.980TTM2.9800.000
TTM2.980YOY3.740-0.760
TTM2.9805Y3.897-0.917
5Y3.89710Y2.491+1.407
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of China Shineway Pharmaceutical Group Ltd ADR.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Shineway assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Shineway to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.27 means that Shineway assets are financed with 26.5% credit (debt) and the remaining percentage (100% - 26.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of China Shineway Pharmaceutical Group Ltd ADR:

  • The MRQ is 0.265. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.265. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.265TTM0.2650.000
TTM0.265YOY0.225+0.041
TTM0.2655Y0.200+0.066
5Y0.20010Y0.176+0.024
4.5.4.2. Debt to Equity Ratio

Measures if Shineway is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Shineway to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 36.1% means that company has $0.36 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of China Shineway Pharmaceutical Group Ltd ADR:

  • The MRQ is 0.361. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.361. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.361TTM0.3610.000
TTM0.361YOY0.290+0.071
TTM0.3615Y0.255+0.106
5Y0.25510Y0.218+0.037
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Shineway generates.

  • Above 15 is considered overpriced but always compare Shineway to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 36.80 means the investor is paying $36.80 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of China Shineway Pharmaceutical Group Ltd ADR:

  • The EOD is 36.274. Based on the earnings, the company is overpriced. -1
  • The MRQ is 36.802. Based on the earnings, the company is overpriced. -1
  • The TTM is 36.802. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD36.274MRQ36.802-0.529
MRQ36.802TTM36.8020.000
TTM36.802YOY4.492+32.310
TTM36.8025Y16.850+19.952
5Y16.85010Y41.467-24.616
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of China Shineway Pharmaceutical Group Ltd ADR:

  • The EOD is 41.391. Based on how much money comes from the company's main activities, the company is fair priced.
  • The MRQ is 41.995. Based on how much money comes from the company's main activities, the company is fair priced.
  • The TTM is 41.995. Based on how much money comes from the company's main activities, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD41.391MRQ41.995-0.603
MRQ41.995TTM41.9950.000
TTM41.995YOY20.431+21.563
TTM41.9955Y60.315-18.320
5Y60.31510Y70.225-9.910
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Shineway is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of China Shineway Pharmaceutical Group Ltd ADR:

  • The EOD is 5.004. Based on the equity, the company is overpriced. -1
  • The MRQ is 5.077. Based on the equity, the company is overpriced. -1
  • The TTM is 5.077. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD5.004MRQ5.077-0.073
MRQ5.077TTM5.0770.000
TTM5.077YOY3.536+1.541
TTM5.0775Y5.726-0.649
5Y5.72610Y6.133-0.407
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets1,349,933
Total Liabilities358,031
Total Stockholder Equity991,902
 As reported
Total Liabilities 358,031
Total Stockholder Equity+ 991,902
Total Assets = 1,349,933

Assets

Total Assets1,349,933
Total Current Assets1,149,817
Long-term Assets200,116
Total Current Assets
Cash And Cash Equivalents 830,317
Short-term Investments 2,820
Net Receivables 186,725
Inventory 126,577
Other Current Assets 3,378
Total Current Assets  (as reported)1,149,817
Total Current Assets  (calculated)1,149,817
+/- 0
Long-term Assets
Property Plant Equipment 169,945
Goodwill 23,400
Intangible Assets 32,790
Other Assets 0
Long-term Assets  (as reported)200,116
Long-term Assets  (calculated)226,135
+/- 26,019

Liabilities & Shareholders' Equity

Total Current Liabilities343,154
Long-term Liabilities14,876
Total Stockholder Equity991,902
Total Current Liabilities
Short-term Debt 42,437
Short Long Term Debt 300,000
Accounts payable 68,356
Other Current Liabilities 214,398
Total Current Liabilities  (as reported)343,154
Total Current Liabilities  (calculated)625,190
+/- 282,036
Long-term Liabilities
Capital Lease Obligations 1,326
Long-term Liabilities  (as reported)14,876
Long-term Liabilities  (calculated)1,326
+/- 13,550
Total Stockholder Equity
Common Stock12,360
Retained Earnings 903,815
Accumulated Other Comprehensive Income 97,794
Other Stockholders Equity -22,068
Total Stockholder Equity (as reported)991,902
Total Stockholder Equity (calculated)991,902
+/-0
Other
Capital Stock87,662
Cash and Short Term Investments 833,137
Common Stock Shares Outstanding 37,770
Current Deferred Revenue17,964
Liabilities and Stockholders Equity 1,349,933
Net Debt -787,830
Net Invested Capital 7,334,768
Net Working Capital 5,721,012
Property Plant and Equipment Gross 3,108,670
Short Long Term Debt Total 42,487



6.2. Balance Sheets Structured

Currency in CNY. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312016-12-312015-12-312014-12-312013-12-31
> Total Assets 
5,738,294
5,907,324
6,153,102
6,465,262
6,731,791
1,023,780
1,103,017
1,130,325
1,184,151
1,349,933
1,349,9331,184,1511,130,3251,103,0171,023,7806,731,7916,465,2626,153,1025,907,3245,738,294
   > Total Current Assets 
3,877,216
3,949,735
3,840,491
4,250,996
4,652,945
746,953
843,915
894,210
975,646
1,149,817
1,149,817975,646894,210843,915746,9534,652,9454,250,9963,840,4913,949,7353,877,216
       Cash And Cash Equivalents 
2,291,905
2,688,148
2,826,219
3,218,401
3,611,485
566,568
648,798
659,892
725,937
830,317
830,317725,937659,892648,798566,5683,611,4853,218,4012,826,2192,688,1482,291,905
       Short-term Investments 
0
0
0
0
0
0
0
0
20,230
2,820
2,82020,23000000000
       Net Receivables 
680,046
593,817
511,864
556,061
549,456
100,069
119,839
135,886
149,969
186,725
186,725149,969135,886119,839100,069549,456556,061511,864593,817680,046
       Inventory 
244,484
285,672
340,858
294,410
405,498
61,846
67,739
92,252
94,604
126,577
126,57794,60492,25267,73961,846405,498294,410340,858285,672244,484
       Other Current Assets 
660,781
382,098
161,550
182,124
79,316
18,470
7,539
6,179
5,136
3,378
3,3785,1366,1797,53918,47079,316182,124161,550382,098660,781
   > Long-term Assets 
0
0
0
0
2,078,846
276,826
259,101
236,115
208,505
200,116
200,116208,505236,115259,101276,8262,078,8460000
       Property Plant Equipment 
1,599,242
1,574,725
1,529,020
1,466,458
1,403,661
214,469
213,274
196,443
175,056
169,945
169,945175,056196,443213,274214,4691,403,6611,466,4581,529,0201,574,7251,599,242
       Goodwill 
91,663
99,654
159,291
159,291
159,291
22,868
15,673
26,039
23,873
23,400
23,40023,87326,03915,67322,868159,291159,291159,29199,65491,663
       Intangible Assets 
518
23,286
388,744
348,353
287,920
58,509
21,324
36,462
30,684
32,790
32,79030,68436,46221,32458,509287,920348,353388,74423,286518
       Long-term Assets Other 
0
0
0
0
0
-22,868
20,970
-26,039
-23,873
4,623
4,623-23,873-26,03920,970-22,86800000
> Total Liabilities 
1,308,678
1,014,416
857,131
838,589
966,010
186,709
185,788
177,439
266,026
358,031
358,031266,026177,439185,788186,709966,010838,589857,1311,014,4161,308,678
   > Total Current Liabilities 
1,180,000
885,985
701,608
673,056
780,273
169,115
182,680
172,338
239,595
343,154
343,154239,595172,338182,680169,115780,273673,056701,608885,9851,180,000
       Short-term Debt 
500,000
200,000
0
0
0
57,862
57,664
1,190
939
42,437
42,4379391,19057,66457,862000200,000500,000
       Short Long Term Debt 
500,000
200,000
0
0
0
398,392
369,319
0
0
300,000
300,00000369,319398,392000200,000500,000
       Accounts payable 
219,579
202,487
224,126
219,126
213,107
27,197
25,135
35,871
44,413
68,356
68,35644,41335,87125,13527,197213,107219,126224,126202,487219,579
       Other Current Liabilities 
449,091
476,436
474,190
437,844
379,307
77,270
89,534
121,801
172,217
214,398
214,398172,217121,80189,53477,270379,307437,844474,190476,436449,091
   > Long-term Liabilities 
0
0
0
0
185,737
17,594
3,108
5,101
26,431
14,876
14,87626,4315,1013,10817,594185,7370000
       Capital Lease Obligations 
0
0
0
0
0
6,145
22,819
14,911
7,442
1,326
1,3267,44214,91122,8196,14500000
> Total Stockholder Equity
4,429,094
4,892,471
5,295,971
5,626,673
5,765,781
829,339
885,988
925,962
918,124
991,902
991,902918,124925,962885,988829,3395,765,7815,626,6735,295,9714,892,4714,429,094
   Common Stock
87,662
87,662
87,662
87,662
87,662
12,585
13,404
13,754
12,610
12,360
12,36012,61013,75413,40412,58587,66287,66287,66287,66287,662
   Retained Earnings 
3,476,290
3,908,155
4,293,902
4,623,035
5,410,649
754,599
812,171
841,848
834,472
903,815
903,815834,472841,848812,171754,5995,410,6494,623,0354,293,9023,908,1553,476,290
   Capital Surplus 0000000000
   Treasury Stock0000000000
   Other Stockholders Equity 
97,754
129,266
147,019
148,588
-154,670
-18,108
-24,859
-24,557
-22,514
-22,068
-22,068-22,514-24,557-24,859-18,108-154,670148,588147,019129,26697,754



6.3. Balance Sheets

Currency in CNY. All numbers in thousands.




6.4. Cash Flows

Currency in CNY. All numbers in thousands.




6.5. Income Statements

Currency in CNY. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in CNY. All numbers in thousands.

Gross Profit (+$)
totalRevenue637,476
Cost of Revenue-158,421
Gross Profit479,055479,055
 
Operating Income (+$)
Gross Profit479,055
Operating Expense-342,133
Operating Income136,922136,922
 
Operating Expense (+$)
Research Development15,591
Selling General Administrative326,499
Selling And Marketing Expenses1,981,623
Operating Expense342,1332,323,713
 
Net Interest Income (+$)
Interest Income95,207
Interest Expense-2,737
Other Finance Cost-0
Net Interest Income92,470
 
Pretax Income (+$)
Operating Income136,922
Net Interest Income92,470
Other Non-Operating Income Expenses-
Income Before Tax (EBT)175,05398,791
EBIT - interestExpense = 134,185
175,053
139,576
Interest Expense2,737
Earnings Before Interest and Taxes (EBIT)136,922177,790
Earnings Before Interest and Taxes (EBITDA)145,423
 
After tax Income (+$)
Income Before Tax175,053
Tax Provision-270,743
Net Income From Continuing Ops969,510-95,690
Net Income136,839
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses500,555
Total Other Income/Expenses Net38,131-92,470
 

Technical Analysis of Shineway
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Shineway. The general trend of Shineway is BEARISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Shineway's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-57.1%) Bearish trend (57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of China Shineway Pharmaceutical Group Ltd ADR.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 18.53 < 22.08 < 22.08.

The bearish price targets are: 18.53 > 18.53 > 18.53.

Tweet this
China Shineway Pharmaceutical Group Ltd ADR Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of China Shineway Pharmaceutical Group Ltd ADR. The current mas is .

The long score for the Moving Averages is 3/14.
The longshort score for the Moving Averages is -8/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

China Shineway Pharmaceutical Group Ltd ADR Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of China Shineway Pharmaceutical Group Ltd ADR. The current macd is -0.9597785.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Shineway price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Shineway. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Shineway price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
China Shineway Pharmaceutical Group Ltd ADR Daily Moving Average Convergence/Divergence (MACD) ChartChina Shineway Pharmaceutical Group Ltd ADR Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of China Shineway Pharmaceutical Group Ltd ADR. The current adx is 84.67.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Shineway shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
China Shineway Pharmaceutical Group Ltd ADR Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of China Shineway Pharmaceutical Group Ltd ADR. The current sar is 20.56.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
China Shineway Pharmaceutical Group Ltd ADR Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of China Shineway Pharmaceutical Group Ltd ADR. The current rsi is 0.05031569. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 1/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
China Shineway Pharmaceutical Group Ltd ADR Daily Relative Strength Index (RSI) ChartChina Shineway Pharmaceutical Group Ltd ADR Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of China Shineway Pharmaceutical Group Ltd ADR. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Shineway price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
China Shineway Pharmaceutical Group Ltd ADR Daily Stochastic Oscillator ChartChina Shineway Pharmaceutical Group Ltd ADR Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of China Shineway Pharmaceutical Group Ltd ADR. The current cci is -60.60606061.

China Shineway Pharmaceutical Group Ltd ADR Daily Commodity Channel Index (CCI) ChartChina Shineway Pharmaceutical Group Ltd ADR Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of China Shineway Pharmaceutical Group Ltd ADR. The current cmo is -99.99913595.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
China Shineway Pharmaceutical Group Ltd ADR Daily Chande Momentum Oscillator (CMO) ChartChina Shineway Pharmaceutical Group Ltd ADR Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of China Shineway Pharmaceutical Group Ltd ADR. The current willr is -100.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
China Shineway Pharmaceutical Group Ltd ADR Daily Williams %R ChartChina Shineway Pharmaceutical Group Ltd ADR Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of China Shineway Pharmaceutical Group Ltd ADR.

China Shineway Pharmaceutical Group Ltd ADR Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of China Shineway Pharmaceutical Group Ltd ADR. The current atr is 0.12120707.

China Shineway Pharmaceutical Group Ltd ADR Daily Average True Range (ATR) ChartChina Shineway Pharmaceutical Group Ltd ADR Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of China Shineway Pharmaceutical Group Ltd ADR. The current obv is 1,770.

China Shineway Pharmaceutical Group Ltd ADR Daily On-Balance Volume (OBV) ChartChina Shineway Pharmaceutical Group Ltd ADR Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of China Shineway Pharmaceutical Group Ltd ADR. The current mfi is 0.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
China Shineway Pharmaceutical Group Ltd ADR Daily Money Flow Index (MFI) ChartChina Shineway Pharmaceutical Group Ltd ADR Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for China Shineway Pharmaceutical Group Ltd ADR.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-04-29CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-05-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-05-17MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-05-29WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-06-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-08-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

China Shineway Pharmaceutical Group Ltd ADR Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of China Shineway Pharmaceutical Group Ltd ADR based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than500.050
Ma 20Greater thanMa 5020.128
Ma 50Greater thanMa 10021.299
Ma 100Greater thanMa 20021.975
OpenGreater thanClose18.530
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Shineway with someone you think should read this too:
  • Are you bullish or bearish on Shineway? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Shineway? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about China Shineway Pharmaceutical Group Ltd ADR

I send you an email if I find something interesting about China Shineway Pharmaceutical Group Ltd ADR.


Comments

How you think about this?

Leave a comment

Stay informed about China Shineway Pharmaceutical Group Ltd ADR.

Receive notifications about China Shineway Pharmaceutical Group Ltd ADR in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.